Akineton Injection
Biperiden
5mg/ml
KNOLL AG
| Pack size | 1ml Ampoule x 5 |
|---|---|
| Dispensing mode | POM |
| Source | GERMANY |
| Agent | GULF DRUG EST. |
| Retail Price | 14.00 AED |
Indications
Akineton Injection is used for:
Drug-induced extrapyramidal symptoms (but not tardive dyskinesias) and adjunctive treatment of parkinsonism.
Adult Dose
Drug–induced extrapyramidal symptoms, parkinsonism, by mouth, ADULT (as biperiden hydrochloride), initially 1 mg twice daily, increased gradually to 2 mg 3 times daily; usual maintenance dose 3–12 mg daily in divided doses.
Drug–induced extrapyramidal symptoms, parkinsonism, by IM injection or slow IV injection, ADULT (as biperiden lactate), 2.5–5 mg repeated as necessary to maximum 20 mg in 24 hours
Child Dose
Renal Dose
Administration
Contra Indications
Angle-closure glaucoma;
Untreated urinary retention;
Prostatic hypertrophy;
Myasthenia gravis;
GI obstruction.
Precautions
Elderly;
Cardiovascular disease;
Hepatic or renal impairment;
Avoid abrupt withdrawal;
Pregnancy and breastfeeding
Pregnancy-Lactation
Recommendations on the use of Biperiden in Pregnancy & Lactation:
There is limited experience with the use of Biperiden during pregnancy and lactation. There has been no documented report of significant adverse effects (Schaefer et al., 2015). It should be used only when the benefit outweighs potential risks.
Reference:
1. Schaefer, C., Peters, P., & Miller, R. K. (2015). Drugs During Pregnancy and Lactation: Treatment Options and Risk Assessment (Third Edition). Academic Press
Interactions
Adverse Effects
Side effects of Biperiden :
Mechanism of Action
Note
Akineton 5mg/ml Injection manufactured by KNOLL AG. Its generic name is Biperiden. Akineton is availble in United Arab Emirates.
Farmaco UAE drug index information on Akineton Injection is not intended for diagnosis, medical advice or treatment; neither intended to be a substitute for the exercise of professional judgment.